| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Medical Physics Agency, Royal Group of Hospitals, Grosvenor Road, and 2 Radiation Oncology and 3 Medical Physics Agency, Northern Ireland Cancer Centre, Belfast City Hospital, Belfast
Correspondence: Kathryn Carson, Nuclear Medicine Department, Level 1, Imaging Centre, Royal Victoria Hospital, Belfast BT12 6BA, UK. E-mail: kathryn.carson{at}mpa.n-i.nhs.uk
The acquisition of radiotherapy planning scans on positron emission tomography (PET)–CT scanners requires the involvement of radiotherapy radiographers. This study assessed the radiation dose received by these radiographers during this process. Radiotherapy planning 18F-fluorodeoxyglucose (18F-FDG) PET–CT scans were acquired for 28 non-small cell lung cancer patients. In order to minimise the radiation dose received, a two-stage process was used in which the most time-consuming part of the set-up was performed before the patient received their 18F-FDG injection. Throughout this process, the radiographers wore electronic personal dosemeters and recorded the doses received at different stages of the process. The mean total radiation dose received by a radiotherapy radiographer was 5.1±2.6 µSv per patient. The use of the two-stage process reduced the time spent in close proximity to the patient by approximately a factor of four. The two-stage process was effective in keeping radiation dose to a minimum. The use of a pre-injection set-up session reduces the radiation dose to the radiotherapy radiographers because of their involvement in PET–CT radiotherapy treatment planning scans by approximately a factor of three.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| BJR | DMFR | IMAGING | ALL BIR JOURNALS |